https://ift.tt/dVQz2lX HOUSTON, May 26, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced a Trials in Progress poster presentation at the 2022 American Society of Clinical Oncology Annual Meeting being held in Chicago, IL June 3-7, 2022. The Trials in Progress poster presentation will summarize the adaptive trial design, dosing regimen, and follow up strategy for Alaunos’ ongoing TCR-T Library Phase 1/ from Yahoo Canada Sports - Sports News, Scores, Rumours, Fantasy Games, and more https://ift.tt/aGzJvZu